Jae Park, MD, Memorial Sloan Kettering Cancer Center

home / authors / jae-park-md-memorial-sloan-kettering-cancer-center

Articles

Expert on Leukemia

ASH 2021: Updates in the Chronic Lymphocytic Leukemia Treatment Landscape

February 14th 2022

Following the ASH 2021 annual meeting, expert hematologist/oncologists discuss updates in chronic lymphocytic leukemia.

Read More

Expert on Leukemia

ASH 2021: Key Data in Chronic Myeloid Leukemia

February 7th 2022

Shared insight on updates in the chronic myeloid leukemia treatment landscape following the ASH 2021 annual meeting.

Read More

Expert on Leukemia

ASH 2021: Novel Therapy in Acute Lymphocytic Leukemia

January 31st 2022

Expert perspectives on clinical data readouts in acute lymphocytic leukemia from the ASH 2021 annual meeting.

Read More

ASH Updates for CAR T-Cell Therapy in Acute Lymphoblastic Leukemia

ASH Updates for CAR T-Cell Therapy in Acute Lymphoblastic Leukemia

March 4th 2021

Read More

Evolving Field of Acute Lymphoblastic Leukemia

Evolving Field of Acute Lymphoblastic Leukemia

March 4th 2021

Read More

Investigational CAR T-Cell Therapy in Acute Lymphoblastic Leukemia

Investigational CAR T-Cell Therapy in Acute Lymphoblastic Leukemia

February 25th 2021

Read More

CAR T-Cell Therapy Use in Second Line Acute Lymphoblastic Leukemia

CAR T-Cell Therapy Use in Second Line Acute Lymphoblastic Leukemia

February 25th 2021

Read More

CAR T-Cell Therapy After First Relapse of Acute Lymphoblastic Leukemia

CAR T-Cell Therapy After First Relapse of Acute Lymphoblastic Leukemia

February 18th 2021

Read More

Approach to Managing Relapsed Acute Lymphoblastic Leukemia

Approach to Managing Relapsed Acute Lymphoblastic Leukemia

February 18th 2021

Read More

Role of Transplant in Older Adults With Acute Lymphoblastic Leukemia

Role of Transplant in Older Adults With Acute Lymphoblastic Leukemia

February 11th 2021

Read More

Managing MRD-Negative Acute Lymphoblastic Leukemia

Managing MRD-Negative Acute Lymphoblastic Leukemia

February 11th 2021

Read More

Managing MRD-Positive Acute Lymphoblastic Leukemia

Managing MRD-Positive Acute Lymphoblastic Leukemia

February 4th 2021

Read More

Treatment of Acute Lymphoblastic Leukemia in the Community Setting

Treatment of Acute Lymphoblastic Leukemia in the Community Setting

February 4th 2021

Read More

Role of MRD Testing in Acute Lymphoblastic Leukemia

Role of MRD Testing in Acute Lymphoblastic Leukemia

January 28th 2021

Read More

Treating Older Adult Patients With Philadelphia Chromosome-Negative ALL

Treating Older Adult Patients With Philadelphia Chromosome-Negative ALL

January 28th 2021

Read More

Treating Young Adult Patients With Philadelphia Chromosome-Negative ALL

Treating Young Adult Patients With Philadelphia Chromosome-Negative ALL

January 21st 2021

Read More

Treating Older Adult Patients With Philadelphia Chromosome-Positive ALL

Treating Older Adult Patients With Philadelphia Chromosome-Positive ALL

January 13th 2021

Read More

Treating Young Adult Patients With Philadelphia Chromosome–Positive ALL

Treating Young Adult Patients With Philadelphia Chromosome–Positive ALL

January 13th 2021

Read More

Prognostic Factors Which Impact ALL Management

Prognostic Factors Which Impact ALL Management

January 13th 2021

Read More

Advice for Community Oncologists on Treating HCL

Advice for Community Oncologists on Treating HCL

June 30th 2020

Read More

Treatments for Relapsed/Refractory HCL in Pipeline

Treatments for Relapsed/Refractory HCL in Pipeline

June 30th 2020

Read More

The Role of CD22-targeted Immunotoxins in HCL

The Role of CD22-targeted Immunotoxins in HCL

June 30th 2020

Read More

Landscape Change in the Treatment of Relapsed/Refractory HCL

Landscape Change in the Treatment of Relapsed/Refractory HCL

June 30th 2020

Read More

Historical Treatment for Relapsed/Refractory HCL

Historical Treatment for Relapsed/Refractory HCL

June 30th 2020

Read More

When to Not Use Combination and the Need for Bone Marrow Biopsy in HCL

When to Not Use Combination and the Need for Bone Marrow Biopsy in HCL

June 30th 2020

Read More

Combination First-line Therapy in Hairy Cell Leukemia

Combination First-line Therapy in Hairy Cell Leukemia

June 30th 2020

Read More

Determining When to Treat and First-Line Therapy for HCL

Determining When to Treat and First-Line Therapy for HCL

June 30th 2020

Read More

Differential Diagnosis and Molecular Tests in Identifying HCL

Differential Diagnosis and Molecular Tests in Identifying HCL

June 30th 2020

Read More

Signs and Tests for Diagnosis and Prognosis of HCL

Signs and Tests for Diagnosis and Prognosis of HCL

June 30th 2020

Read More

Molecular Genetic Changes for Hairy Cell Leukemia

Molecular Genetic Changes for Hairy Cell Leukemia

June 30th 2020

Read More

12>